ImmunoPrecise Antibodies Ltd.

NasdaqGM:IPA Stock Report

Mkt Cap: US$82.6m

ImmunoPrecise Antibodies Management

How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Jennifer Bath





Dr. Jennifer Lynne Bath, Ph D, has been the Chief Executive Officer and President of ImmunoPrecise Antibodies Ltd. since February 21, 2018.Dr. Bath served as the Global Director of Client Relations at Ald...

CEO Compensation Analysis

How has Jennifer Bath's remuneration changed compared to ImmunoPrecise Antibodies's earnings?
DateTotal Comp.SalaryCompany Earnings
Jan 31 2023n/an/a


Oct 31 2022n/an/a


Jul 31 2022n/an/a


Apr 30 2022CA$2mCA$649k


Jan 31 2022n/an/a


Oct 31 2021n/an/a


Jul 31 2021n/an/a


Apr 30 2021CA$2mCA$503k


Jan 31 2021n/an/a


Oct 31 2020n/an/a


Jul 31 2020n/an/a


Apr 30 2020CA$673kCA$488k


Jan 31 2020n/an/a


Oct 31 2019n/an/a


Jul 31 2019n/an/a


Apr 30 2019CA$1mCA$505k


Jan 31 2019n/an/a


Oct 31 2018n/an/a


Jul 31 2018n/an/a


Apr 30 2018CA$65kCA$65k


Leadership Team

Jennifer Bath
CEO, President & Non-Independent Director5.08yrsCA$1.86m0.79%
CA$ 649.0k
Brad McConn
Chief Financial Officer0.58yrCA$432.71k0.032%
CA$ 26.5k
Ilse Roodink
Chief Scientific Officer1.67yrsCA$514.16k0.013%
CA$ 11.1k
David Orton
Chief Operating Officer6yrsno datano data
Roland Romijn
Head of General Operations of the Utrecht site of IPA (Europe)no datano datano data


Average Tenure

Board Members

Jennifer Bath
CEO, President & Non-Independent Director4.83yrsCA$1.86m0.79%
CA$ 649.0k
James Kuo
Independent Chairman of the Board6.25yrsCA$130.84k0.10%
CA$ 82.9k
Lisa Helbling
CA$ 6.6k
Gregory Smith
Independent Director6.5yrsCA$95.66k0.29%
CA$ 243.6k
Guy Champagne
Member of Advisory Board4.58yrsCA$55.00kno data
Robert Burke
Independent Director5.25yrsCA$87.99k0.12%
CA$ 102.7k
Dion Neame
Member of Strategic Advisory Board1.83yrsno datano data


Average Tenure


Average Age